How to verify research-grade Tirzepatide in Canada: read a COA line by line, tell HPLC purity from mass-spec identity, and spot fake or underdosed vials.
PandaPeptide Research Team
Ardavan Z is a Canadian peptide research specialist and founder of Panda Peptide. With deep expertise in research-grade peptides and in-vitro laboratory compounds, Ardavan is committed to supplying licensed Canadian researchers with the highest-purity peptides on the market.
Retatrutide vs. Cagrilintide: Inside the 2026 GLP-1 Race (And Everything Else Coming Next)
Research use only. This article is written for licensed researchers and educational reference. Retatrutide and cagrilintide are investigational/research compounds in Canada and are not approved for human or animal use. For most of the last two years, “which GLP-1 compound is winning” has really meant one comparison: retatrutide vs semaglutide. We’ve covered that match-up in […]
Tirzepatide vs Semaglutide vs Retatrutide: How the Three Compare
Research use only. Everything below is written for qualified researchers. Semaglutide and tirzepatide are approved medicines in some countries, but the material discussed here is sold strictly as a research compound and is not for human use. On this page Tirzepatide vs semaglutide: the short version One receptor, two, or three What the weight-loss numbers […]
Retatrutide in Canada: The Complete 2026 Research Guide
Research use only. The information below is provided for licensed researchers and educational reference. Retatrutide is an investigational compound and is not approved for human consumption in Canada or elsewhere. On this page What is retatrutide? Is retatrutide available in Canada? 2026 Phase 3 results Retatrutide vs tirzepatide vs semaglutide Reconstitution basics Sourcing Retatrutide Canada […]
Retatrutide vs Semaglutide: Testimonial Comparison
A deep-dive comparison drawing on Phase 3 TRIUMPH trial data, r/Retatrutide community reports, and Panda Peptide client experiences. The data makes a clear case.
Retatrutide vs Semaglutide: 2026 Phase 3 Meta-Analysis
Last updated: May 2026 — incorporates TRIUMPH-1 topline data (released May 21, 2026), TRIUMPH-4 (December 2025), and TRANSCEND-T2D-1 (March 2026). When we first wrote this comparison in late 2024, retatrutide had only Phase 2 data to its name — a remarkable 24.2% weight loss that outpaced every approved drug on the market. We said Phase […]
BPC-157 vs CJC-1295 No DAC: Two Very Different Peptides That Keep Getting Compared
They show up in the same conversations. Both injectable. Both popular. Both ending up in the same research protocols. And almost every comparison you’ll find online treats them like competing options — as if you’re supposed to pick one. That framing is wrong. BPC-157 and CJC-1295 No DAC don’t compete any more than a wound […]